635.00
+15.00
+(2.42%)
At close: January 31 at 8:10:16 AM GMT+1
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
--
-420,327.00
-862,807.00
-606,812.00
-398,463.00
Investing Cash Flow
--
308,210.00
-461,184.00
-347,070.00
344,692.00
Financing Cash Flow
--
1,336,727.00
843,757.00
1,121,342.00
833,003.00
End Cash Position
--
2,048,844.00
800,740.00
1,334,676.00
1,216,803.00
Capital Expenditure
--
-43,812.00
-103,823.00
-121,434.00
-5,139.00
Issuance of Capital Stock
--
1,196,731.00
760,953.00
1,091,326.00
813,186.00
Repayment of Debt
--
-3,801.00
-4,165.00
-3,855.00
-2,550.00
Free Cash Flow
--
-464,139.00
-966,630.00
-728,246.00
-403,602.00
12/31/2020 - 5/23/2019
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
1BT.F Enlivex Therapeutics Ltd.
1.0500
0.00%
F6T.MU Fate Therapeutics Inc
1.2810
0.00%
HQ1.MU Oruka Therapeutics Inc. R
12.00
+5.26%
UCBJF UCB SA
195.25
0.00%
GYX.F Futura Medical plc
0.1750
-50.00%
PI3.DU Gubra AS
88.40
-0.23%
CVAC.VI CureVac N.V.
3.6780
-2.13%
ASCLF Ascletis Pharma Inc.
0.2393
0.00%
HPHA.DE Heidelberg Pharma AG
2.3900
-2.45%
471A.F aTyr Pharma, Inc.
3.5800
+3.47%